topicFenugreek Cardiometabolic Randomized Trial
claimIt is often associated with hormonal imbalance, metabolic disturbances, and reproductive complications, which together contribute to an elevated risk of long-term cardiometabolic disorders.
evidence level4
citationSingnale P (2026)
sourceRole of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review.
topicFenugreek Cardiometabolic Randomized Trial
claimTo narratively synthesize mechanistic rationale and human clinical evidence on dietary seeds and selected nutraceuticals relevant to PCOS, with emphasis on metabolic and reproductive endpoints of interest to nutrition and obstetrics/gynecology practice.
evidence level4
citationSingnale P (2026)
sourceRole of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review.
topicFenugreek Cardiometabolic Randomized Trial
claimProposed "seed cycling" protocols have received attention, yet most clinical data are derived from mixed-seed supplementation studies or low-level evidence, such as case reports, and should be considered hypothesis-generating.
evidence level4
citationSingnale P (2026)
sourceRole of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review.
topicFenugreek Cardiometabolic Randomized Trial
claimPolycystic ovary syndrome (PCOS) represents one of the most common endocrine disorders among women of reproductive age.
evidence level4
citationSingnale P (2026)
sourceRole of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review.
topicFenugreek Cardiometabolic Randomized Trial
claimMacrovascular complications, such as coronary heart disease, peripheral vascular disease, and cerebrovascular disease are the leading cause of morbidity and mortality in the United States.In India patients with T2D exhibited a two-fold risk of coronary artery disease-related deaths compared with white, T2D Europeans.
evidence level4
citationRao Amit S. (2020)
sourceNigella sativa and Trigonella foenum-graecum Supplemented Chapatis Safely Improve HbA1c, Body Weight, Waist Circumference, Blood Lipids, and Fatty Liver in Overweight and Diabetic Subjects: A Twelve-Week Safety and Efficacy Study
topicFenugreek Cardiometabolic Randomized Trial
claimBased on the reported efficacy of these two spices, we hypothesized that the fortified chapatis would normalize glycemic variables, as well as variables associated with hepatic and cardiovascular disease risk.
evidence level4
citationRao Amit S. (2020)
sourceNigella sativa and Trigonella foenum-graecum Supplemented Chapatis Safely Improve HbA1c, Body Weight, Waist Circumference, Blood Lipids, and Fatty Liver in Overweight and Diabetic Subjects: A Twelve-Week Safety and Efficacy Study
topicFenugreek Cardiometabolic Randomized Trial
claimOne-half of theseed powder (2.5% of the formulated Atta flour) was a defatted seed powder produced by supercritical carbon dioxide extraction ().As a result of flour supplementation, the fat content increased by 49%, representing 66% and 48% increases in monounsaturated fatty acids and polyunsaturated fatty acids, respectively.
evidence level4
citationRao Amit S. (2020)
sourceNigella sativa and Trigonella foenum-graecum Supplemented Chapatis Safely Improve HbA1c, Body Weight, Waist Circumference, Blood Lipids, and Fatty Liver in Overweight and Diabetic Subjects: A Twelve-Week Safety and Efficacy Study
topicFenugreek Cardiometabolic Randomized Trial
claim1 i 2 2 ii 3 It has been estimated that in 2019, ∼ 463 million people globally were diabetic (∼90% type 2 diabetes mellitus [DM]), with China (25.1%), India (16.6%), and the United States (6.69%) representing nearly 50% of that total.
evidence level4
citationRao Amit S. (2020)
sourceNigella sativa and Trigonella foenum-graecum Supplemented Chapatis Safely Improve HbA1c, Body Weight, Waist Circumference, Blood Lipids, and Fatty Liver in Overweight and Diabetic Subjects: A Twelve-Week Safety and Efficacy Study